Literature DB >> 19522546

ETS2 regulating neurodegenerative signaling pathway of human neuronal (SH-SY5Y) cells exposed to single and repeated low-dose sarin (GB).

Arjunan Pachiappan1, Maung Maung Thwin, Loke Weng Keong, Fook Kay Lee, Jayapal Manikandan, Viswanathan Sivakumar, Ponnampalam Gopalakrishnakone.   

Abstract

The mechanistic understanding of low-level sarin-induced neurotoxicity after single or repeated doses has yet to be explored at a cellular level. Using the microarray (Affymetrix-GeneChips) transcription profiling approach, the present study examined gene expression in human SH-SY5Y cells exposed to single (3 and 24 h) or repeated (2 x 24 h) doses of sarin (5 microg/mL) to delineate the possible mechanism. Two hundred twenty-four genes whose expression was significantly (P < 0.01) altered by at least 3-fold were selected by GeneSpringGX analysis. The comparative gene expression data confirmed the transcriptional changes to be related to dose and exposure time of sarin. The effect of a single noncytotoxic sarin dose on gene transcription was variable, whereas repeated doses over 48 h persistently down-regulated genes linked to neurodegenerative mechanisms. Thirty persistently altered genes were validated using real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Similar qRT-PCR profiles obtained in sarin-treated SH-SY5Y and HCN-1A cells confirmed the cell-independent alterations in expression levels. Genes (ETS2, APOE, PSEN1, DDC, and CD9) implicated mainly in the regulation of sarin-induced neuropathogenesis were further confirmed by Western blot and double-immunofluorescence assays. The regulome pathway suggests a new feasible mechanism by which sarin increases ETS2 expression and takes control over other genes involved in the neurodegenerative pathway. The overall data delineate an in vitro experimental model suitable for studying the neuropathology of cells and may provide novel insights into therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19522546     DOI: 10.1021/tx8003467

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  4 in total

1.  Toxicogenomic studies of human neural cells following exposure to organophosphorus chemical warfare nerve agent VX.

Authors:  Xiugong Gao; Hsiuling Lin; Radharaman Ray; Prabhati Ray
Journal:  Neurochem Res       Date:  2013-02-26       Impact factor: 3.996

Review 2.  Targeting G protein coupled receptor-related pathways as emerging molecular therapies.

Authors:  Abdelaziz Ghanemi
Journal:  Saudi Pharm J       Date:  2013-08-13       Impact factor: 4.330

3.  Suppression of CCT3 inhibits melanoma cell proliferation by downregulating CDK1 expression.

Authors:  Wenlou Liu; Xiuli Zhang; Cheng Chen; Yizhi Li; Chunsheng Yang; Zhengxiang Han; Guan Jiang; Yanqun Liu
Journal:  J Cancer       Date:  2022-03-28       Impact factor: 4.207

4.  Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes.

Authors:  Golime RamaRao; Prachiti Afley; Jyothiranjan Acharya; Bijoy Krishna Bhattacharya
Journal:  BMC Neurosci       Date:  2014-04-04       Impact factor: 3.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.